Ticker: MCRB

Seres Therapeutics, Inc. (NASDAQ: MCRB) has recently navigated significant developments following the sale of its VOWST Business to Société des Produits Nestlé S.A. on September 30, 2024. This transaction was pivotal in shaping the company's financial and operational landscape. Key Highlights fro...

**Company Overview:** Seres Therapeutics, Inc. (NASDAQ: MCRB), a clinical-stage biotechnology firm focused on improving patient outcomes through live biotherapeutics, recently reported its quarterly financial results for the period ending March 31, 2025. **Positive Aspects of the Income Statement...